Immediate Impact
5 by Nobel laureates 9 from Science/Nature 59 standout
Citing Papers
Nanomedicine Remodels Tumor Microenvironment for Solid Tumor Immunotherapy
2024 Standout
Immune checkpoint therapy—current perspectives and future directions
2023 StandoutNobel
Works of Renaud Grépin being referenced
The combination of bevacizumab/Avastin and erlotinib/Tarceva is relevant for the treatment of metastatic renal cell carcinoma: the role of a synonymous mutation of the EGFR receptor
2019
Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells
2011
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Renaud Grépin | 588 | 269 | 272 | 26 | 892 | |
| Qianshan Ding | 517 | 191 | 251 | 42 | 842 | |
| Jinah Park | 766 | 255 | 179 | 32 | 1.0k | |
| Wendy Prime | 657 | 358 | 276 | 24 | 1.1k | |
| Kai Doberstein | 515 | 293 | 248 | 26 | 1.1k | |
| Ming Li | 610 | 209 | 250 | 29 | 924 | |
| Chitra Joseph | 373 | 343 | 252 | 35 | 874 | |
| Takuji Mori | 508 | 503 | 250 | 31 | 1.0k | |
| Shiv Ram Krishn | 672 | 358 | 340 | 29 | 1.0k | |
| Robert Cornelison | 755 | 294 | 228 | 28 | 1.1k | |
| Mikkel G. Terp | 613 | 391 | 328 | 42 | 1.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...